# KEVZARA
> **BLA761037** · Biologics License Application · Sponsor: SANOFI SYNTHELABO · Approved 2017-05-22
## Drug
- **FDA Application Number:** BLA761037
- **Application type:** Biologics License Application
- **Brand name:** KEVZARA
- **Generic name:** SARILUMAB
- **Active ingredients:** SARILUMAB
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** SANOFI SYNTHELABO
- **Manufacturer:** Sanofi-Aventis U.S. LLC
- **First approval:** 2017-05-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761037)
---
*MORVS · CC0 1.0*